These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12212559)

  • 21. Motor performance deterioration accelerates after 50 years of age in Charcot-Marie-Tooth type 1A patients.
    Tozza S; Bruzzese D; Pisciotta C; Iodice R; Esposito M; Dubbioso R; Ruggiero L; Topa A; Spina E; Santoro L; Manganelli F
    Eur J Neurol; 2018 Feb; 25(2):301-306. PubMed ID: 29053907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fits, feet and HIV: lessons from a case of coexisting epilepsy and neuropathy in a patient with perinatally acquired HIV-1 infection.
    Freeman-Romilly N; Mewasingh L; Coomer A; Foster C
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30333199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibromatosis type 1 associated with Charcot-Marie-Tooth type 1A.
    Koc F; Guzel AI
    J Dermatol; 2009 May; 36(5):306-11. PubMed ID: 19383003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The motor function measure to study limitation of activity in children and adults with Charcot-Marie-Tooth disease.
    Allard L; Rode G; Jacquin-Courtois S; Pouget MC; Rippert P; Hamroun D; Poirot I; Bérard C; Vuillerot C;
    Ann Phys Rehabil Med; 2014 Dec; 57(9-10):587-99. PubMed ID: 25311851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotype and clinical evolution of Charcot-Marie-Tooth disease type 1A duplication.
    Berciano J; García A; Gallardo E; Ramón C; Combarros O
    Adv Exp Med Biol; 2009; 652():183-200. PubMed ID: 20225026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
    Núñez M; Soriano V
    J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
    [No Abstract]   [Full Text] [Related]  

  • 27. Biomechanical effects of sensorimotor orthoses in adults with Charcot-Marie-Tooth disease.
    Wegener C; Wegener K; Smith R; Schott KH; Burns J
    Prosthet Orthot Int; 2016 Aug; 40(4):436-46. PubMed ID: 25934421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pes cavus pathogenesis in Charcot-Marie-Tooth disease type 1A.
    Burns J; Ouvrier R
    Brain; 2006 Jul; 129(Pt 7):E50; author reply E51. PubMed ID: 16803835
    [No Abstract]   [Full Text] [Related]  

  • 29. Alternatively sized duplication in Charcot-Marie-Tooth disease type 1A.
    Valentijn LJ; Baas F; Zorn I; Hensels GW; de Visser M; Bolhuis PA
    Hum Mol Genet; 1993 Dec; 2(12):2143-6. PubMed ID: 8111385
    [No Abstract]   [Full Text] [Related]  

  • 30. De novo partial duplication of 17p associated with Charcot-Marie-Tooth disease type 1A.
    Fernández-Torre JL; Otero B; Alvarez V; Hernando I; Fernández-Toral J
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):703-4. PubMed ID: 11336036
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication.
    Garcia CA; Malamut RE; England JD; Parry GS; Liu P; Lupski JR
    Neurology; 1995 Nov; 45(11):2090-3. PubMed ID: 7501164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hypothesis of overwork weakness in Charcot-Marie-Tooth: a critical evaluation.
    van Pomeren M; Selles RW; van Ginneken BT; Schreuders TA; Janssen WG; Stam HJ
    J Rehabil Med; 2009 Jan; 41(1):32-4. PubMed ID: 19197566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV co-infected patients.
    Bader T
    J Viral Hepat; 2010 Mar; 17(3):227. PubMed ID: 19758277
    [No Abstract]   [Full Text] [Related]  

  • 34. Diaphragmatic dysfunction in siblings with hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease).
    Chan CK; Mohsenin V; Loke J; Virgulto J; Sipski ML; Ferranti R
    Chest; 1987 Apr; 91(4):567-70. PubMed ID: 3829750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic appendectomy in a pediatric patient with type 1 Charcot-Marie-Tooth disease.
    Heller JA; Marn RY
    J Clin Anesth; 2015 Dec; 27(8):680-1. PubMed ID: 26403061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic manifestations in French-Canadian populations with Charcot-Marie-Tooth disease type 1A associated with 17p11.2 duplication.
    Dupré N; Bouchard JP; Cossette L; Brunet D; Vanasse M; Lemieux B; Mathon G; Puymirat J
    Ann N Y Acad Sci; 1999 Sep; 883():497-9. PubMed ID: 10586283
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune reactivation and paradoxical worsening in an HIV-infected tuberculosis patient.
    de Lange WC
    Adv Exp Med Biol; 2003; 531():261-6. PubMed ID: 12916798
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-HIV agents. Hepatitis C treatment and possible interactions with anti-HIV drugs.
    TreatmentUpdate; 2004; 16(3):2-4. PubMed ID: 17216833
    [No Abstract]   [Full Text] [Related]  

  • 39. Sonography of the median nerve in Charcot-Marie-Tooth disease.
    Martinoli C; Schenone A; Bianchi S; Mandich P; Caponetto C; Abbruzzese M; Derchi LE
    AJR Am J Roentgenol; 2002 Jun; 178(6):1553-6. PubMed ID: 12034637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Charcot-Marie-Tooth disease type 1A: a clinical, electrophysiological, pathological, and genetic study.
    Hsieh SY; Kuo HC; Chu CC; Lin KP; Huang CC
    Chang Gung Med J; 2004 Apr; 27(4):300-6. PubMed ID: 15239197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.